Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.

Smith, Tyrel T

Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. [electronic resource] - The Journal of clinical investigation Jun 2017 - 2176-2191 p. digital

Publication Type: Journal Article

1558-8238

10.1172/JCI87624 doi


Adoptive Transfer
Animals
Antigen-Presenting Cells--physiology
Antineoplastic Agents--administration & dosage
Biopolymers--administration & dosage
Carcinoma, Pancreatic Ductal--immunology
Cell Line, Tumor
Cyclic GMP--administration & dosage
Drug Carriers--administration & dosage
Female
Implants, Experimental
Melanoma, Experimental--immunology
Membrane Proteins--agonists
Mice, Inbred C57BL
Mice, Transgenic
Neoplasm Transplantation
Pancreatic Neoplasms--immunology
T-Lymphocytes--physiology